| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 254,138 | 228,373 | 198,389 | 209,471 | | Cost of Revenue | (223,654) | 136,271 | 42,278 | 45,105 | | | Gross Profit | 477,792 | 92,102 | 156,111 | 164,366 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 393,148 | 24,550 | 101,465 | 102,810 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7,779 | 8,319 | 9,523 | 9,557 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 76,865 | 59,233 | 45,123 | 51,999 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,786 | 3,705 | 1,224 | 410 | | Earnings Before Interest And Taxes | 113,333 | 62,938 | 46,347 | 52,409 | | Interest Expense | 8,413 | 8,446 | 8,407 | 8,416 | | Income Before Tax | 104,920 | 54,492 | 37,940 | 43,993 | | Income Tax Expense | 21,211 | 21,507 | 10,866 | 17,460 | | Minority Interest | (2,003) | (1,599) | (1,213) | (603) | | | | Net Income From Continuing Ops | 289,779 | 31,223 | 25,753 | 24,697 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,434 | 31,223 | 25,753 | 24,697 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,434 | $31,223 | $25,753 | $24,697 |
|
0.05% Nasdaq 
0.128 (0.40%) 
Income Statement
